Cover Image

Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer

First-line treatment of patients with recurrent, metastatic prostate cancer involves hormone therapy with or without additional systemic therapies. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) allows the detection of oligometastatic disease th...

Full description

Saved in:
Bibliographic Details
Main Authors: Körber, Stefan A. (Author) , Sprute, Katharina (Author) , Kratochwil, Clemens (Author) , Winter, Erik (Author) , Häfner, Matthias (Author) , Katayama, Sonja (Author) , Schlampp, Ingmar (Author) , Herfarth, Klaus (Author) , Kopka, Klaus (Author) , Afshar-Oromieh, Ali (Author) , Zschäbitz, Stefanie (Author) , Holland-Letz, Tim (Author) , Choyke, Peter L. (Author) , Jäger, Dirk (Author) , Hohenfellner, Markus (Author) , Haberkorn, Uwe (Author) , Debus, Jürgen (Author) , Giesel, Frederik L. (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: European journal of nuclear medicine and molecular imaging
Year: 2021, Volume: 48, Issue: 1, Pages: 143-151
ISSN:1619-7089
DOI:10.1007/s00259-020-04777-z
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00259-020-04777-z
Get full text
Author Notes:Stefan A. Koerber, Katharina Sprute, Clemens Kratochwil, Erik Winter, Matthias F. Haefner, Sonja Katayama, Ingmar Schlampp, Klaus Herfarth, Klaus Kopka, Ali Afshar-Oromieh, Stefanie Zschaebitz, Tim Holland-Letz, Peter L. Choyke, Dirk Jaeger, Markus Hohenfellner, Uwe Haberkorn, Juergen Debus, Frederik L. Giesel
Description
Summary:First-line treatment of patients with recurrent, metastatic prostate cancer involves hormone therapy with or without additional systemic therapies. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) allows the detection of oligometastatic disease that may be amenable to image-guided radiotherapy. The current study classifies the type and localization of metastases and the clinical outcome of PSMA-PET/CT-guided radiotherapy to selected metastases.
Item Description:Published: 13 May 2020
Gesehen am 11.08.2021
Physical Description:Online Resource
ISSN:1619-7089
DOI:10.1007/s00259-020-04777-z

Similar Items